|MDACC Study No:||2013-0302 (clinicaltrials.gov NCT No: NCT01829711)|
|Title:||A Pivotal Multicenter Trial of Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia|
|Principal Investigator:||Farhad Ravandi-Kashani|
|Study Description:||The goal of this clinical research study is to learn if moxetumomab pasudotox |
can help to control HCL. The safety of this drug will also be studied.